×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VXRT – vaxart, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VXRT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/31
07:59 pm
vxrt
RFK Jr.'s layoffs expected to gut worker safety agency NIOSH, officials say [CBS News]
Medium
Report
RFK Jr.'s layoffs expected to gut worker safety agency NIOSH, officials say [CBS News]
3/27
01:22 pm
vxrt
Vaxart, Inc. (NASDAQ: VXRT) had its price target lowered by analysts at B. Riley from $2.50 to $2.00. They now have a "buy" rating on the stock.
Low
Report
Vaxart, Inc. (NASDAQ: VXRT) had its price target lowered by analysts at B. Riley from $2.50 to $2.00. They now have a "buy" rating on the stock.
3/27
08:00 am
vxrt
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/20
04:01 pm
vxrt
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
High
Report
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
3/13
08:00 am
vxrt
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20
Medium
Report
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20
3/11
08:00 am
vxrt
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate
Low
Report
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate
3/5
07:06 pm
vxrt
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults [Yahoo! Finance]
Medium
Report
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults [Yahoo! Finance]
3/5
04:05 pm
vxrt
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults
Low
Report
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/1
06:46 pm
vxrt
Form 4 Vaxart, Inc. For: Mar 28 Filed by: Cummings James F.
Medium
Report
Form 4 Vaxart, Inc. For: Mar 28 Filed by: Cummings James F.
4/1
04:54 pm
vxrt
Form 4 Vaxart, Inc. For: Mar 28 Filed by: Tucker Sean
High
Report
Form 4 Vaxart, Inc. For: Mar 28 Filed by: Tucker Sean
3/31
05:09 pm
vxrt
Form PRE 14A Vaxart, Inc. For: May 21
Medium
Report
Form PRE 14A Vaxart, Inc. For: May 21
3/26
09:55 pm
vxrt
Form 4 Vaxart, Inc. For: Mar 24 Filed by: Lo Steven
Medium
Report
Form 4 Vaxart, Inc. For: Mar 24 Filed by: Lo Steven
3/26
09:54 pm
vxrt
Form 4 Vaxart, Inc. For: Mar 24 Filed by: Tucker Sean
Medium
Report
Form 4 Vaxart, Inc. For: Mar 24 Filed by: Tucker Sean
3/26
09:53 pm
vxrt
Form 4 Vaxart, Inc. For: Mar 24 Filed by: Lee Phillip E
Medium
Report
Form 4 Vaxart, Inc. For: Mar 24 Filed by: Lee Phillip E
3/26
09:52 pm
vxrt
Form 4 Vaxart, Inc. For: Mar 24 Filed by: Berg Edward B
Medium
Report
Form 4 Vaxart, Inc. For: Mar 24 Filed by: Berg Edward B
3/26
09:52 pm
vxrt
Form 4 Vaxart, Inc. For: Mar 24 Filed by: Cummings James F.
Medium
Report
Form 4 Vaxart, Inc. For: Mar 24 Filed by: Cummings James F.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/31
Vaxart Announces Initiation of Coronavirus Vaccine Program
43.7%
2/26 Vaxart Inc (NASDAQ: VXRT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 31.2%
4/24 Form DEFA14A Vaxart, Inc. 20.0%
8/8 Q2/2019 6/30/2019 EPS -0.390 ZacksConsensus -0.500 ActVsEst 0.110 - Beat 19.0%
9/27 Form POS AM Vaxart, Inc. 18.6%
4/14 Form 8-K Vaxart, Inc. For: Apr 13 15.3%
2/1 Vaxart Inc (NASDAQ: VXRT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 14.4%
1/22 Results from Influenza Challenge Study Published in Lancet Infectious Diseases 13.4%
11/22 Form SC 13D/A Vaxart, Inc. Filed by: ARMISTICE CAPITAL, LLC 11.8%
4/21 Thinking about buying stock in Carnival Corp, MGM Resorts, Teekay Tankers, Uber, or Vaxart? 10.9%
2/26 Vaxart Inc (NASDAQ: VXRT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 31.2%
4/24 Form DEFA14A Vaxart, Inc. 20.0%
8/8 Q2/2019 6/30/2019 EPS -0.390 ZacksConsensus -0.500 ActVsEst 0.110 - Beat 19.0%
9/27 Form POS AM Vaxart, Inc. 18.6%
4/14 Form 8-K Vaxart, Inc. For: Apr 13 15.3%
2/1 Vaxart Inc (NASDAQ: VXRT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 14.4%
1/22 Results from Influenza Challenge Study Published in Lancet Infectious Diseases 13.4%
11/22 Form SC 13D/A Vaxart, Inc. Filed by: ARMISTICE CAPITAL, LLC 11.8%
4/21 Thinking about buying stock in Carnival Corp, MGM Resorts, Teekay Tankers, Uber, or Vaxart? 10.9%
TOP News Decliners
9/25
Vaxart’s Tableted Oral Bivalent Norovirus Vaccine Meets Primary and Secondary Endpoints in Phase 1b Study
-49.1%
4/30 Vaxart Inc (NASDAQ: VXRT) had its price target raised by analysts at HC Wainwright from $3.00 to $7.00. -22.0%
3/19 Vaxart Inc (NASDAQ: VXRT) had its "buy" rating re-affirmed by analysts at HC Wainwright. -17.9%
9/11 Form S-1 Vaxart, Inc. -15.1%
4/28 Vaxart Announces Corporate Update for First Quarter 2020 -13.9%
9/26 Vaxart Announces Pricing of $8 Million Underwritten Public Offering -13.2%
3/19 Form 8-K Vaxart, Inc. For: Mar 18 -12.2%
3/18 IMV up 53% premarket on coronavirus vaccine plan [Seeking Alpha] -9.7%
2/11 Form SC 13G/A Vaxart, Inc. Filed by: BML Investment Partners, L.P. -8.5%
4/29 Form 8-K Vaxart, Inc. For: Apr 28 -8.3%
4/30 Vaxart Inc (NASDAQ: VXRT) had its price target raised by analysts at HC Wainwright from $3.00 to $7.00. -22.0%
3/19 Vaxart Inc (NASDAQ: VXRT) had its "buy" rating re-affirmed by analysts at HC Wainwright. -17.9%
9/11 Form S-1 Vaxart, Inc. -15.1%
4/28 Vaxart Announces Corporate Update for First Quarter 2020 -13.9%
9/26 Vaxart Announces Pricing of $8 Million Underwritten Public Offering -13.2%
3/19 Form 8-K Vaxart, Inc. For: Mar 18 -12.2%
3/18 IMV up 53% premarket on coronavirus vaccine plan [Seeking Alpha] -9.7%
2/11 Form SC 13G/A Vaxart, Inc. Filed by: BML Investment Partners, L.P. -8.5%
4/29 Form 8-K Vaxart, Inc. For: Apr 28 -8.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: